Aerovate Therapeutics
AVTE
#9165
Rank
$73.14 M
Marketcap
$2.53
Share price
-1.17%
Change (1 day)
-85.12%
Change (1 year)

Aerovate Therapeutics (AVTE) - Net assets

Net assets on the balance sheet as of September 2024 : $80.49 Million USD

According to Aerovate Therapeutics's latest financial reports the company has $80.49 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Aerovate Therapeutics - Net assets on balance sheet (from 2020 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$$0.12 B-26.49%
2021-12-31$$0.17 B-1392.1%
2020-12-31$-$13.35 Million266.29%
2019-12-31$-$3.65 Million